Prothena Corp Public PRTA
NASDAQ PRTA
$8.54 +0.16 (+1.91%)
At close: Oct 1, 2026 · 4:00 PM EDT

Prothena Corp Public (PRTA) Liabilities and Shareholders Equity (2012 - 2026)

Updated

Prothena Corp Public's Liabilities and Shareholders Equity was $302.58 million in Q2 2026, down 24.2% from $399.07 million a year earlier and down 13.5% from the prior quarter.

Analysis

Prothena Corp Public (PRTA) Liabilities and Shareholders Equity (2012 - 2026) Analysis & Trends

At the end of FY2025, Liabilities and Shareholders Equity at Prothena Corp Public came in at $326.8 million, down 40.3% from FY2024.

  • Liabilities and Shareholders Equity has now declined for three consecutive years, with a five-year compound annual growth rate of -0.4% (FY2020 to FY2025).
  • In earlier years, Liabilities and Shareholders Equity was $547.11 million in FY2024 (-21.4%), $696.38 million in FY2023 (-8.1%), $758.04 million in FY2022 (+24.4%) and $609.37 million in FY2021 (+83.0%).
  • The Q2 2026 figure marks the lowest quarterly Liabilities and Shareholders Equity since Q1 2015.
  • Compared with a year earlier, Liabilities and Shareholders Equity has declined for 11 straight quarters, with an average decline of 29.4% over the last eight quarters.
  • The best year-over-year quarter for Liabilities and Shareholders Equity over five years was Q4 2021 (growth of 83.0%); the worst was Q3 2025 (a decline of 40.8%).
  • Per Business Quant data, PRTA's Liabilities and Shareholders Equity in the three quarters before Q2 2026 was $349.89 million (Q1 2026), $326.8 million (Q4 2025) and $352.63 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Prothena Corp Public 433.62 Mn -822.46 Mn - 302.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 302.58 Mn
Mar 31, 2026 349.89 Mn
Dec 31, 2025 326.80 Mn
Sep 30, 2025 352.63 Mn
Jun 30, 2025 399.07 Mn
Mar 31, 2025 495.34 Mn
Dec 31, 2024 547.11 Mn
Sep 30, 2024 595.25 Mn
Jun 30, 2024 645.57 Mn
Mar 31, 2024 623.19 Mn
Dec 31, 2023 696.38 Mn
Sep 30, 2023 746.92 Mn
Jun 30, 2023 720.65 Mn
Mar 31, 2023 741.59 Mn
Dec 31, 2022 758.04 Mn
Sep 30, 2022 554.44 Mn
Jun 30, 2022 549.59 Mn
Mar 31, 2022 581.41 Mn
Dec 31, 2021 609.37 Mn
Sep 30, 2021 632.70 Mn
API Access

Prothena Corp Public Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=PRTA&period=max&api_key=YOUR_API_KEY